Illumina, Inc. (ILMN) SEC Filings & Earnings Calls

CP program increases short-term debt exposure; reliance on commercial paper market conditions

“short-term, unsecured commercial paper notes” · word for word

Higher interest expense on new notes (4.950% vs 4.650%) increases annual interest cost.

“Notes accrue interest at a rate of 4.950% per annum.”

Refinancing risk is low; no covenant or liquidity stress indicated.

“Proceeds used to repay existing notes; no new net debt.”

Litigation risk removed; no financial impact.

“Settlement with mutual releases and no payment.”

China regulatory risk (unreliable entities list)

“Total revenue in Q2 2026 and YTD 2026 was impacted by a decrease in revenue from our Greater China region of $7 million and $27 million, respectively, primarily due to our inclusion on the unreliable entities list.” · word for word

Tariff cost pressure

“Excluding this impact, gross margin decreased primarily due to higher tariff costs.” · word for word

Litigation risk (GRAIL-related lawsuits)

“We are involved in various lawsuits and claims arising in the ordinary course of business, including actions with respect to intellectual property, employment, and contractual matters.” · word for word

Memory chip cost inflation

“The decrease in Q2 2026 is primarily due to ... rising memory costs.” · word for word

China inclusion on Unreliable Entities List and tariff uncertainty pose risks.

“Uncertainty regarding impact of inclusion on China's Unreliable Entities List; tariffs imposed by U.S. and trading partners.”

China unreliable entities list

“Total revenue in Q1 2026 was impacted, across all products and services, by a decrease in revenue in our Greater China region of $20 million primarily due to our inclusion on the unreliable entities list.” · word for word

Tariff cost pressure

“We have incurred significant costs under IEEPA-related tariffs since their implementation.” · word for word

NIH funding reduction

“reductions in the U.S. government's funding of the NIH” · word for word

Geopolitical conflict impact

“As a result of the conflict and instability in Iran and elsewhere in the Middle East, we expect higher fuel and energy costs to increase freight and shipping costs throughout 2026.” · word for word

Memory chip cost inflation

“We also expect costs and margins in 2026 to be impacted by the rising costs to purchase memory chips.” · word for word

Exposure to China regulatory risks and tariffs could impact future results

“uncertainty regarding our inclusion on the 'unreliable entities list' by regulatory authorities in China; uncertainty regarding tariffs imposed or threatened by the U.S. government”

Integration risks from SomaLogic acquisition

“our ability to successfully integrate SomaLogic, Inc. and certain other assets” · word for word

China export prohibition

“The Company was prohibited from exporting sequencing instruments into China” · word for word

NIH funding cuts

“the U.S. government implemented cuts to National Institutes of Health (NIH) grants upon which many Illumina research customers rely” · word for word

Tariff exposure

“various trade tariffs were adopted or increased by governments around the world” · word for word

Board turnover

“Drs. Arnold, Epstein and Guthart will conclude their service on the Board at the close of the 2026 annual meeting of stockholders.” · word for word

China Unreliable Entities List

“Total revenue in 2025 was impacted, across all products and services, by a decrease in revenue in our Greater China region of $65 million, primarily due to our inclusion on the List of Unreliable Entities.” · word for word

NIH Funding Reduction

“some customers, specifically research customers, continue to manage inventory and capital more conservatively and some labs are delaying projects due to funding concerns.” · word for word

Tariff Cost Pressure

“Gross margin decreased primarily due to higher costs related to tariffs” · word for word

China exposure: MOFCOM lifted export ban but company remains on Unreliable Entities List.

“Company remains on Unreliable Entities List (UEL) in China, requiring approvals for instrument purchases.”

Integration risk and uncertainty in proteomics market; forward-looking statements highlight challenges.

“Cautionary notes on forward-looking statements cite integration, technology development, and market acceptance risks.”

China regulatory and tariff risks: inclusion on 'unreliable entities list' and potential tariffs create headwinds for China revenue.

“uncertainty regarding the impact of our inclusion on the 'unreliable entities list' by regulatory authorities in China; uncertainty regarding tariffs imposed or threatened by the U.S. government and its trading partners” · word for word

SomaLogic acquisition integration risk: proposed acquisition of SomaLogic business from Standard BioTools faces regulatory and integration uncertainties.

“the completion of the proposed acquisition of SomaLogic, Inc. and certain other assets (the SomaLogic Business) from Standard BioTools Inc. on the anticipated terms and timeline, or at all, including the ability of the parties to obtain required regulatory approvals” · word for word

Loss of chief commercial officer may impact sales execution.

“CCO departing for CEO role at another company.”

New debt increases leverage, but refinancing extends maturity and reduces near-term refinancing risk.

“Offering of $500M notes due 2030; proceeds used to repay $500M notes due Dec 2025.”

Increased leverage; proceeds used for acquisition and debt repayment.

“Proceeds for general corporate purposes, which may include repayment of its 5.800% notes due December 12, 2025 and the completion of the proposed acquisition of SomaLogic.”

China Export Ban

“In Q1 2025, we were added to the unreliable entities list by regulatory authorities in China and received notice that we are not permitted to export sequencing instruments into China.” · word for word

Tariff Cost Pressure

“Core Illumina gross margin decreased in Q3 2025 and YTD 2025 primarily due to higher tariff costs.” · word for word

NIH Funding Reduction

“Some customers, specifically research customers, continue to manage inventory and capital more conservatively and some labs are delaying projects due to funding concerns.” · word for word

Litigation Risk

“We are involved in various lawsuits and claims arising in the ordinary course of business, including actions with respect to intellectual property, employment, and contractual matters.” · word for word

Macroeconomic Uncertainty

“Macroeconomic factors such as tariffs, inflation, exchange rate fluctuations and concerns about an economic downturn, competitive challenges in our China region, the sanctions imposed on Russia as a result of the armed conflict between Russia and Ukraine, and reductions in the U.S. government’s funding of the NIH have impacted both Illumina directly and our ” · word for word

China revenue headwind persists

“Revenue growth outside of China in the range of 0.5% - 1.5% on a constant currency basis, implying China drag” · word for word